Jakob Vasehus Schou
Overview
Explore the profile of Jakob Vasehus Schou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piper K, Suetta C, Schou J, Ryg J, Andersen H, Langevad L, et al.
J Geriatr Oncol
. 2024 Apr;
15(4):101770.
PMID: 38631243
Introduction: Older patients with cancer range from fit to frail with various comorbidities and resilience to chemotherapy. Besides nausea and fatigue, a significant number of patients experience dizziness and impaired...
2.
Meltzer S, Torgunrud A, Abrahamsson H, Solbakken A, Flatmark K, Dueland S, et al.
Br J Cancer
. 2021 Apr;
125(2):240-246.
PMID: 33837301
Background: In colorectal cancer, the inflamed tumour microenvironment with its angiogenic activities is immune- tolerant and incites progression to liver metastasis. We hypothesised that angiogenic and inflammatory factors in serum...
3.
Meltzer S, Bakke K, Rod K, Negard A, Flatmark K, Solbakken A, et al.
Clin Transl Radiat Oncol
. 2019 Dec;
21:5-10.
PMID: 31872084
Background And Purpose: We investigated how features relating to pelvic cavity anatomy and tumor hemodynamic factors may influence systemic failure in rectal cancer. Materials And Methods: Rectal cancer patients (207...
4.
Boysen A, Schou J, Spindler K
Clin Transl Oncol
. 2018 Dec;
21(7):874-880.
PMID: 30506526
Background: Preoperative chemoradiotherapy is the standard of care for patients with locally advanced rectal cancer, yet valid circulating biomarkers are lacking. We aimed at systematically reviewing the literature of cell-free...
5.
Kalanxhi E, Meltzer S, Schou J, Larsen F, Dueland S, Flatmark K, et al.
Br J Cancer
. 2018 Apr;
118(10):1322-1328.
PMID: 29695770
Background: Systemic failure remains a challenge in rectal cancer. We investigated the possible systemic anti-tumour immune activity invoked within oxaliplatin-based neoadjuvant therapy. Methods: In two high-risk patient cohorts, we assessed...
6.
Schou J, Johansen J, Nielsen D, Rossi S
Noncoding RNA
. 2018 Apr;
2(2).
PMID: 29657263
MiRNAs are suggested as promising cancer biomarkers. They are stable and extractable from a variety of clinical tissue specimens (fresh frozen or formalin fixed paraffin embedded tissue) and a variety...
7.
Skougaard K, Johannesen H, Nielsen D, Schou J, Jensen B, Hogdall E, et al.
Cancer Med
. 2014 Jun;
3(5):1294-301.
PMID: 24941936
We compared morphologic computed tomography (CT)-based to metabolic fluoro-deoxy-glucose (FDG) positron emission tomography (PET)/CT-based response evaluation in patients with metastatic colorectal cancer and correlated the findings with survival and KRAS...